Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer

Gynecologic Oncology
A MunkarahDavid M Gershenson

Abstract

The aim of this study was to evaluate the role of secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer with an apparent solitary intra-abdominal focus. We conducted a retrospective review of patients with epithelial ovarian cancer who underwent secondary cytoreduction for recurrence at the University of Texas M. D. Anderson Cancer Center between 1985 and 1994. Eligible patients included those who had a laparotomy to resect a tumor that was apparently solitary. Cytoreductive surgery was defined as optimal if the diameter of the largest residual tumor was < or =2 cm and suboptimal if >2 cm. Twenty-five patients met our eligibility criteria. Their mean age was 55 years (range, 35-73 years). The median time from primary diagnosis to recurrence was 37.6 months. Tumor was found to be confined to a solitary site in 15 patients (60%), to two sites in 6 (24%), and to three or more sites in 4 (16%). Surgical procedures included cytoreduction in 10 patients, intestinal resection in 8, splenectomy in 3, and limited biopsies in 4. Secondary cytoreduction was optimal in 18 of 25 patients (72%). The median postsecondary cytoreduction survival was 25.1 months for patients who had suboptimal secondary cytoreducti...Continue Reading

References

Sep 1, 1989·Gynecologic Oncology·M MorrisC A Stringer
Sep 1, 1988·Gynecologic Oncology·K C PodratzT O Wilson
Jul 15, 1981·Cancer·J T Wharton, J Herson

❮ Previous
Next ❯

Citations

Aug 30, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H OksefjellC Tropé
Jul 2, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S TangjitgamolJ J Kavanagh
Dec 2, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·L ChenC B Powell
Aug 25, 2012·International Journal of Surgical Oncology·D LorussoF Raspagliesi
Mar 15, 2013·JSLS : Journal of the Society of Laparoendoscopic Surgeons·Farr R NezhatPrakash Saharia
Sep 24, 2004·Gynecologic Oncology·Mario M LeitaoDennis S Chi
Sep 8, 2006·Annals of Surgical Oncology·Natalina ManciPierluigi Bendetti Panici
Sep 30, 2006·Annals of Surgical Oncology·Philipp HarterUNKNOWN AGO Ovarian Cancer Study Group
Jan 2, 2007·Annals of Surgical Oncology·Pierluigi Benedetti PaniciRoberto Angioli
Aug 13, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·R-Y ZangS-M Cai
Feb 13, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A GadducciE Sartori
Oct 14, 2005·Current Oncology Reports·Teresa P Díaz-Montes, Robert E Bristow
Nov 15, 2006·The Journal of Obstetrics and Gynaecology Research·Aya MatsumotoShingo Fujii
Aug 20, 2010·Journal of Surgical Oncology·Ioannis BiliatisAris Antsaklis
Sep 26, 2013·Journal of Experimental & Clinical Cancer Research : CR·Xia XuJing Ni
Oct 22, 2003·Surgical Oncology Clinics of North America·Marcello DeracoShigeki Kusamura
Oct 12, 2007·Expert Opinion on Pharmacotherapy·Susan C Modesitt, Amir A Jazaeri
May 1, 2016·Gynecologic Oncology·Dong Hoon SuhRobert E Bristow
Jul 30, 2005·Gynecologic Oncology·Robert E BristowRichard L Wahl
Mar 2, 2013·The Cochrane Database of Systematic Reviews·Thuria Al RawahiKhadra Galaal
Sep 5, 2002·Cancer·Robert E BristowFredrick J Montz
May 27, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Peter J FrederickCharles N Landen
Nov 21, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Rafli van de LaarLeon F A G Massuger
Jan 16, 2007·Current Opinion in Obstetrics & Gynecology·Jan Hauspy, Allan Covens
Jul 9, 2010·Journal of Gynecologic Oncology·Karin K Shih, Dennis S Chi
Jul 4, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Gilles HouvenaeghelDamien Castaigne
Aug 12, 2005·Current Opinion in Oncology·Philipp Harter, Andreas du Bois
Aug 23, 2002·Current Opinion in Oncology·Emery SalomRamin Mirhashemi
Jun 26, 2007·Gynecologic Oncology·Stephen J TebesMitchel S Hoffman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Obstetrics, Gynecology, and Reproductive Biology
G CormioL Selvaggi
Gynécologie, obstétrique & fertilité
B ZylberbergJ M Antoine
AJR. American Journal of Roentgenology
Stacey A FuntDennis S Chi
© 2021 Meta ULC. All rights reserved